$15.1 B

DGX Mkt cap, 14-Jun-2018

$1.9 B

Quest Diagnostics Revenue Q1, 2018
Quest Diagnostics Gross profit (Q1, 2018)658 M
Quest Diagnostics Gross profit margin (Q1, 2018), %34.9%
Quest Diagnostics Net income (Q1, 2018)189 M
Quest Diagnostics EBIT (Q1, 2018)272 M
Quest Diagnostics Cash, 31-Mar-2018124 M
Quest Diagnostics EV18.8 B

Quest Diagnostics Revenue Breakdown

Embed Graph

Quest Diagnostics revenue breakdown by business segment: 95.0% from Diagnostic Information Services and 5.0% from Other

Quest Diagnostics Financials

Quest Diagnostics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

7.1 b7.4 b7.5 b7.5 b

Revenue growth, %

4%1%0%

Cost of goods sold

4.3 b4.6 b4.7 b4.6 b

Gross profit

2.8 b2.8 b2.8 b2.9 b

Gross profit Margin, %

39%38%38%39%

EBIT

1.5 b983 m1.4 b1.3 b

EBIT margin, %

21%13%19%17%

Interest expense

159 m164 m153 m143 m

Income tax expense

500 m262 m(373 m)(429 m)

Net Income

883 m592 m753 m696 m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

1.8 b1.7 b1.9 b1.9 b1.8 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b

Cost of goods sold

1.1 b1.1 b1.2 b1.2 b1.2 b1.2 b1.2 b1.1 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b

Gross profit

698.6 m645 m728 m726 m676 m743 m718 m719 m751 m728 m734 m773 m741 m658 m

Gross profit Margin, %

39%37%38%38%37%39%38%39%39%39%39%40%38%35%

General and administrative expense

423 m415 m440 m446 m419 m429 m402 m442 m430 m409 m437 m437 m423 m363 m

Operating expense total

1.1 b1.5 b1.6 b1.6 b1.6 b1.6 b1.2 b442 m430 m409 m437 m437 m423 m363 m

Depreciation and amortization

22 m

EBIT

689.5 m208 m262 m256 m228 m301 m631 m257 m422 m322 m279 m319 m298 m272 m

EBIT margin, %

39%12%14%13%12%16%34%14%22%17%15%16%15%14%

Interest expense

40 m39 m42 m41 m45 m37 m35 m36 m34 m37 m36 m38 m38 m41 m

Pre tax profit

112 m207 m

Income tax expense

245.9 m65 m87 m82 m42 m78 m(239 m)(68 m)(183 m)(95 m)(78 m)(94 m)(92 m)(52 m)

Net Income

413.9 m111 m142 m139 m70 m129 m354 m114 m209 m205 m175 m207 m175 m189 m

Quest Diagnostics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

187 m192 m133 m359 m

Inventories

91 m110 m84 m82 m

Current Assets

1.4 b1.6 b1.5 b1.5 b

PP&E

805 m933 m925 m1 b

Goodwill

5.6 b6 b5.9 b6 b

Total Assets

8.9 b9.9 b10 b10.1 b

Accounts Payable

920 m1.2 b1 b975 m

Short-term debt

212 m518 m159 m6 m

Current Liabilities

1.1 b1.7 b1.2 b981 m

Long-term debt

3.1 b3.2 b3.5 b3.7 b

Total Debt

3.3 b3.8 b3.7 b3.7 b

Additional Paid-in Capital

2.4 b2.4 b2.5 b2.5 b

Retained Earnings

5.4 b5.7 b6.2 b6.6 b

Total Equity

4 b4.3 b4.7 b4.7 b

Debt to Equity Ratio

0.8 x0.9 x0.8 x0.8 x

Debt to Assets Ratio

0.4 x0.4 x0.4 x0.4 x

Financial Leverage

2.3 x2.3 x2.1 x2.2 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

158.3 m144 m144 m170 m974 m150 m123 m128 m283 m406 m367 m314 m350 m124 m

Inventories

85.2 m99 m109 m111 m106 m109 m86 m82 m80 m82 m77 m83 m100 m94 m

Current Assets

1.4 b1.5 b1.5 b1.6 b2.4 b1.5 b1.6 b1.5 b1.5 b1.6 b1.6 b1.5 b1.5 b1.4 b

PP&E

749.4 m851 m884 m888 m902 m906 m886 m925 m937 m952 m1 b1 b1.1 b1.2 b

Goodwill

5.6 b5.9 b6 b6 b6 b6 b5.9 b6 b6 b6 b6 b6.1 b6.2 b6.4 b

Total Assets

8.9 b9.6 b9.8 b9.8 b10.6 b9.7 b10.1 b10.1 b10.1 b10.2 b10.1 b10.2 b10.4 b10.7 b

Accounts Payable

994.3 m969 m1 b1.1 b1 b1.1 b973 m932 m1.1 b1 b979 m912 m1 b976 m

Short-term debt

244.7 m223 m220 m132 m1 b168 m160 m158 m7 m7 m6 m5 m5 m141 m

Current Liabilities

1.2 b1.2 b1.3 b1.2 b2.1 b1.2 b1.1 b1.1 b1.1 b1 b985 m917 m1.1 b1.1 b

Long-term debt

3.1 b3.7 b3.7 b3.7 b3.7 b3.6 b3.6 b3.7 b3.8 b3.8 b3.7 b3.7 b3.8 b3.7 b

Total Debt

3.4 b3.9 b4 b3.9 b4.7 b3.7 b3.7 b3.9 b3.8 b3.8 b3.7 b3.7 b3.8 b3.9 b

Additional Paid-in Capital

2.3 b2.4 b2.4 b2.4 b2.4 b2.4 b2.5 b2.5 b2.5 b2.5 b2.5 b2.6 b2.6 b2.6 b

Retained Earnings

5.3 b5.4 b5.5 b5.6 b5.7 b5.8 b6.1 b6.2 b6.4 b6.5 b6.7 b6.8 b6.9 b7.2 b

Total Equity

3.9 b4 b4.1 b4.2 b4.3 b4.3 b4.6 b4.7 b4.6 b4.7 b4.7 b4.7 b4.8 b5.1 b

Financial Leverage

2.3 x2.4 x2.4 x2.3 x2.5 x2.2 x2.2 x2.2 x2.2 x2.2 x2.2 x2.1 x2.2 x2.1 x

Quest Diagnostics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

883 m592 m753 m696 m

Accounts Receivable

(247 m)(312 m)(262 m)(343 m)

Accounts Payable

(21 m)68 m(31 m)56 m

Cash From Operating Activities

652 m938 m810 m1.1 b

Cash From Investing Activities

328 m(1 b)(362 m)(152 m)

Long-term Borrowings

(900 m)(1.6 b)(2.5 b)(1.7 b)

Dividends Paid

(185 m)(187 m)(212 m)(223 m)

Cash From Financing Activities

(1.1 b)92 m(507 m)(691 m)

Free Cash Flow

883 m1.2 b1.1 b1.4 b

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

732.1 m111 m253 m392 m70 m199 m553 m114 m324 m529 m175 m382 m557 m189 m

Depreciation and Amortization

211 m75 m156 m235 m78 m153 m230 m62 m123 m186 m62 m128 m197 m74 m

Accounts Receivable

(252.4 m)(152 m)(191 m)(260 m)(97 m)(163 m)(214 m)(145 m)(249 m)(316 m)(117 m)(185 m)(265 m)(97 m)

Accounts Payable

(76.8 m)(86 m)(39 m)20 m(120 m)(49 m)(41 m)(77 m)23 m43 m(95 m)(93 m)(3 m)(68 m)

Cash From Operating Activities

441.6 m84 m364 m635 m52 m327 m539 m143 m464 m765 m196 m490 m852 m180 m

Cash From Investing Activities

433.6 m(636 m)(841 m)(934 m)(55 m)(123 m)(237 m)(190 m)27 m(45 m)(22 m)(192 m)(439 m)(204 m)

Long-term Borrowings

(757.2 m)(923 m)(1.2 b)(1.5 b)(440 m)(1.8 b)(2.2 b)(453 m)(1.7 b)(1.7 b)(2 m)(3 m)(5 m)(832 m)

Dividends Paid

(141 m)(43 m)(91 m)(139 m)(48 m)(103 m)(158 m)(55 m)(111 m)(168 m)(62 m)(124 m)(186 m)(61 m)

Cash From Financing Activities

(1 b)509 m434 m282 m785 m(246 m)(371 m)42 m(341 m)(447 m)(166 m)(343 m)(422 m)11 m

Free Cash Flow

286.2 m16 m247 m416 m(4 m)210 m370 m96 m360 m600 m154 m383 m682 m107 m

Quest Diagnostics Ratios

USDY, 2018

EV/EBIT

69.1 x

EV/CFO

104.5 x

EV/FCF

175.7 x

Financial Leverage

2.1 x
Report incorrect company information

Quest Diagnostics Operating Metrics

FY, 2016

Accounts

250 k

Patents Issued

700

Patents Pending

570

Patient Service Centers

2.20 k
Report incorrect company information